medigraphic.com
ISSN 1729-519X (Print)

2022, Number 2

<< Back Next >>

Revista Habanera de Ciencias Médicas 2022; 21 (2)

Successful treatment of Rosai-Dorfman disease with immunomodulators and metronomic chemotherapy

Aliaga-Chávez RA, Bendezú-Huasasquiche LE, Crisol-Deza DA

Language: Spanish
References: 19
Page: 1-4
PDF size: 1491.40 Kb.


ABSTRACT

Introduction: Rosai-Dorfman disease is a massive lymphocytic histiocytosis characterized by emperipolesis with positive immunohistochemistry for S100 and CD68. It is a rare clinical entity of benign course most commonly presenting in males.
Objective: The purpose of this clinical case is to demonstrate successful treatment of Rosai-Dorfman disease with immunomodulators and metronomic chemotherapy.
Case presentation: A 57-year-old male patient presenting with bilateral cervical lymphadenopathy underwent CT scan and lymph node biopsy with positive results for S100 and CD68 with marked emperipolesis phenomenon. He received immunomodulatory scheme and successful metronomic chemotherapy with disease remission.
Conclusions: Patients diagnosed with Rosai-Dorfman are very few due to the unusual nature of this clinical entity. It is important to mention that this disease is a non-Langerhans cell histiocytosis with benign characteristics and good response to management with corticosteroids and metronomic chemotherapy, therapy established in our patient with good evolution.


REFERENCES

  1. Miekus A, Stefanowicz J, Kobierska Gulida G. Rosai-Dorfman disease as a rare cause of cervical lymphadenopathy-case report and literature review. Centr Eur J Immunol. 2018;43(3):341-5.

  2. Acota M, Rodríguez G, Gésime J. Enfermedad de Rosai-Dorfman y sus manifestaciones bucales en un paciente pediátrico. Reporte de un caso. Rev Venez Invest Odont IADR. 2018;6(2):244-53.

  3. O'Gallagher K, Dancy L, Sinha L. Rosai-Dorfman disease and the heart. Intractable & Rare Diseases Research. 2016;5(1):1-5.

  4. Patra?cu V, Filculescu A, Georgescu C, Ciurea R. Cutaneous Rosai-dorfman disease -a clinical case. RoJCED. 2018;5(2):56.

  5. Molina Carrión L, Mendoza Álvarez S, Vera Lastra O. Enfermedad de Rosai-Dorfman y lesiones espinales y craneales. Informe de un caso clínico. Rev Med Inst Mex Seguro Soc. 2014;52(2):218-23.

  6. Maffia S, Peruffo M, Malvaso R. Enfermedad de Rosai-Dorfman. A propósito de un caso. Arch Argent Pediatr. 2015;113(6):327-9.

  7. Arilala F, Mamisoa I, Raharolahy O. Rosai-Dorfman Disease Involving Multiple Organs:An Unusual Case with Poor Prognosis. Case Report in Medicine. 2016; 2016:1-4.

  8. Barrón V, Peláez C. Enfermedad de Rosai Dorfman primario de mama: Reporte de caso. Rev SCientifica. 2017;15(1):24-6.

  9. Yazid P, Ping L, Kiang K. Rosai Dorfman disease: a case report. Int J Otorhinolaryngol Head Neck Surg. 2018;4(2):582-4.

  10. Pemartin B, Gómez Chacón J, Llavador M. Linfadenopatías gigantes de curso benigno: enfermedad de Rosai-Dorfman. An Pediatr (Barc). 2014;81(6):e7-e8.

  11. Primo L, Mestroni M, Allevato M. Enfermedad de Rosai-Dorfman o histiocitosis sinusal con linfadenopatía masiva. Rev Asoc Colomb Dermatol. 2013;21(3):274-9.

  12. Dalia S, Sagatys E, Sokol L. Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control. 2014;21(4):322-7.

  13. Averitt A, Heym K, Akers L. Sinus Histiocytosis With Massive Lymphadenopathy (Rosai Dorfman Disease): Diagnostic and Treatment Modalities for this Rare Entity Revisited. J Pediatr Hematol Oncol. 2018 May;40(4):e198-e202.

  14. Badlissi F, Pihanb G, Corominasa H. Rosai-Dorfman disease: Ultrasonography and histopathology study of a soft tissue mass in the forearm. Reumatol Clin. 2017;30(20):30.

  15. Cai Y, Shi Z, Bai Y. Review of Rosai-Dorfman Disease: New Insights into the Pathogenesis of This Rare Disorder. Acta Haematol. 2017;138(1):14-23.

  16. Abla O, Jacobsen E, Picarsic J. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood Journal. 2018;18(31):34-6.

  17. Scharovsky G, Matar P, Rozados V. Inmunomodulación y Antiangiogénseis en la terapéutica oncológica de la Investigación Básica a la Clínica. Medicina (Buenos Aires). 2012;72:47-57.

  18. Bendersky T, Vago S, Oyarbide Al. Enfermedad de Rosai-Dorfman. Rev Hosp Niños (Buenos Aires) 2020;62(278):159-62.

  19. Zumaeta J, Palacios F, Anicama W, Burgos C. Enfermedad de Rosai-Dorfman intracraneal aislada: Reporte de caso. Peru J Neurosurg 2020; 2(1):15-21.




2020     |     www.medigraphic.com